SPX3,963.51+29.59 0.75%
DIA338.46+2.02 0.60%
IXIC11,082.00+123.45 1.13%

BRIEF-First Wave Biopharma Chairman And CEO Issues Letter To Stockholders

Reuters · 11/16/2022 07:07
BRIEF-First Wave Biopharma Chairman And CEO Issues Letter To Stockholders

- First Wave BioPharma Inc FWBI.O:

  • FIRST WAVE BIOPHARMA CHAIRMAN AND CEO ISSUES LETTER TO STOCKHOLDERS

  • FIRST WAVE BIOPHARMA INC - EXPECT TO FILE AN IND APPLICATION WITH FDA TO EVALUATE AN ENHANCED ENTERIC MICROGRANULE DELIVERY FORMULATION OF ADRULIPASE

  • FIRST WAVE BIOPHARMA INC - EXPECTS TO INITIATE ADRULIPASE PHASE 2 CLINICAL TRIAL PRIOR TO YEAR-END 2022 WITH TOP-LINE DATA ANTICIPATED BY END H1 2023

Source text for Eikon: ID:

Further company coverage: FWBI.O


((Reuters.Briefs@thomsonreuters.com;))